LENZ Therapeutics, Inc. (LENZ)

NASDAQ: LENZ · Real-Time Price · USD

11.59

-0.46 (-3.82%)

At close: Feb 20, 2026, 4:00 PM EST

11.50

-0.09 (-0.78%)

After-hours: Feb 20, 2026, 7:59 PM EST

LENZ Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	363	794	-	-	-
Enterprise Value	161	578	-	-	-
Last Close Price	11.59	28.87	-	-	-
PB Ratio	1.71	3.89	-	-	-
P/TBV Ratio	1.87	3.89	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	-
Net Debt / Equity Ratio	-1.04	-1.02	-1.27	-1.19	-1.07
Net Debt / EBITDA Ratio	2.97	3.55	0.90	4.22	2.74
Net Debt / FCF Ratio	4.36	3.47	1.08	10.71	3.39
Asset Turnover	0.08	-	-	0.46	-
Quick Ratio	12.46	20.09	3.55	4.68	14.61
Current Ratio	12.69	20.36	3.63	4.91	14.62
Return on Equity (ROE)	-28.78%	-38.94%	-157.61%	-39.80%	-
Return on Assets (ROA)	-19.52%	-25.64%	-77.17%	-20.07%	-
Return on Capital Employed (ROCE)	-34.90%	-28.60%	-139.70%	-28.00%	-39.20%
Earnings Yield	-16.24%	-6.27%	-	-	-
FCF Yield	-12.73%	-7.54%	-	-	-
Buyback Yield / Dilution	-87.55%	-986.27%	79.28%	-1.05%	-

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q